Cerevance Media Center

Current News

October 5, 2017

Stanford Neuroscientist, Robert Malenka, M.D., Ph.D., to Advise Cerevance

Cerevance, a drug discovery and development company, today announced that Robert Malenka, M.D., Ph.D., has joined the company as a senior-level scientific advisor.  Dr. Malenka is the Pritzker Professor of Psychiatry and Behavioral Sciences at Stanford University.

READ FULL

May 3, 2017

Dementia Discovery Fund to Invest $5M in Cerevance to Seek New Treatments for Dementia

The Dementia Discovery Fund, an innovative global investment fund managed by SV Life Sciences and launched in 2015 to develop disease modifying drugs for dementia, today announced a $5 million investment in the initial financing round of start-up drug discovery company, Cerevance.

READ FULL

December 2, 2016

Cerevance Launched With New Technology, Drug Portfolio and $36M in Cash to Tackle Brain Diseases

  • Takeda and Lightstone Ventures Participate in Series A Financing
  • Former Takeda Cambridge UK employees, CNS programs moved to create turn-key discovery capabilities
READ FULL

News Archive

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
No items found.

April 2, 2024

Cerevance to Participate at the 23rd Annual Needham Virtual Health Care Conference

Date:
Monday, April 8, 2024
Time:
Check local times
Location:
Virtual
Media:
Scheduled Meetings
Read full

March 13, 2024

Cerevance Announces Presentation at Alzheimer’s Research UK Conference

Date:
Wednesday, March 20, 2024
Time:
Check local times
Location:
Liverpool, United Kingdom
Media:
Poster
Read full

February 27, 2024

Cerevance Announces Presentation at AD/PD™ 2024 International Conference

Date:
Friday, March 8, 2024
Time:
Check local times
Location:
Lisbon, Portugal
Media:
Poster
Read full

Events Archive

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
No items found.

October 21, 2024

CVN424, a GPR6 Inverse Agonist, for Parkinson’s Disease and Motor Fluctuations: A Double-Blind, Randomized, Phase 2 Trial

Brice, Nicola L., Carlton, Mark, Margolin, David H., Bexon, Martin, Matthews, Kim L., Dawson, Lee A., Ellenbogen, Aaron L., Olanow, Warren C., Dubow, Jordan, and Kieburtz, Karl

Viewview

April 30, 2022

A Phase I, First-in-Human, Healthy Volunteer Study to Investigate the Safety, Tolerability, and Pharmacokinetics of CVN424, a Novel G Protein-Coupled Receptor 6 Inverse Agonist for Parkinson’s Disease

Margolin, D.H., Brice, N.L., Davidson, A.M., Matthews, K.L., Carlton, M.B.L.

Viewview

June 30, 2021

Development of CVN424: A Selective and Novel GPR6 Inverse Agonist Effective in Models of Parkinson Disease

Brice, N.L., Schiffer, H.H., Monenschein, H., Mulligan, V.J., Page, K., Powell, J., Xu, X., Cheung, T., Burley, J.R., Sun, H., Dickson, L., Murphy, S.T., Kaushal, N., Sheardown, S., Lawrence, J., Chen, Y., Bartkowski, D., Kanta, A., Hosea, N., Dawson, L.A., Hitchcock, S.H., Carlton, M.B.

Viewview

March 1, 2024

Discovery and First-time Disclosure of CVN766, an Exquisitely Selective Orexin 1 Receptor Antagonist

Glen, A., Bürli, R.W., Livermore, D., Buffham, W., Merison, S., Rowland, A.E., Newman, R., Fieldhouse, C., Miller, D.J., Dawson, L.A., Matthews, K., Carlton, M.B., Brice, N.L.

Viewview

April 5, 2024

Discovery of CVN293, a Brain Permeable KCNK13 (THIK-1) Inhibitor Suitable for Clinical Assessment

Bürli, R. W., Doyle,K. J., Dickson, L., Rowland, A., Matthews, K., Stott, A. J., Teall, M., Ossola, B., Russell, S. G., Harvey, J. R. M., Wu,Y., Narayana, L., Brice, N. L., Carlton, M., Dawson, L. A.

Viewview

February 15, 2023

Characterisation of C101248: A Novel Selective THIK-1 Channel Inhibitor for the Modulation of Microglial NLRP3-Inflammasome

Ossola, B., Rifat, A., Rowland, A., Hunter, H., Drinkall, S., Bender, C., Hamlischer, M., Teall, M., Burley, R., Barke, D., Cadwalladr, D., Dickson, L., Lawrence, J., Harvey, J., Lizio, M., Xu, X., Kavanagh, E., Cheung, T., Sheardown, S., Lawrence, C.B., Harte, M., Brough, D., Madry, C., Matthews, K., Doyle, K., Page, K., Powell, J., Brice, N.L., Bürli, R.W., Carlton, M.B., Dawson L.A.

Viewview